FUJIFILM Cellular Dynamics and Axcelead Drug Discovery Partners are collaborating to provide customers with a human induced pluripotent stem cell (iPSC)-based integrated platform for drug discovery solutions, the company announced recently.

According to a release, the companies will work toward developing new drug efficacy evaluation methods and toxicity testing to meet specific needs of clients. The duo will combine FUJIFILM’s iPSC-derived products and Axcelead’s compound evaluation and analytical services.

Axcelead is a nonclinical drug discovery solution provider, located in Fujisawa, Japan.